Predictmedix AI talks up "multivertical" growth plan

Executive Summary

• Predictmedix AI Inc. announced a strategic pivot to evolve from a single-product health-screening company into a diversified, AI-driven health-technology enterprise.
• The new strategy centers on three complementary growth platforms: a Clinical-trial AI platform, SmartHealth AI stations, and a Consumer vital scanning mobile application.
• The company highlights recurring revenue potential through SaaS subscriptions, screening-as-a-service, and consumer subscriptions, backed by proprietary IP and large addressable markets.

Key Details

• Clinical-trial AI Platform:
  • Described as the primary near-term driver.
  • Developing an adaptive AI engine to simulate, optimize, and predict outcomes across multisite clinical trials.
  • Targeting a global clinical trials market projected to reach $123.5 billion (U.S.) by 2030, with a CAGR of ~6.5% (2024–2030).
  • Features include trial simulation, cross-trial learning, cost/outcome modeling, and full regulatory traceability.
  • Structure is Software-as-a-Service (SaaS).
• SmartHealth AI Stations:
  • Contactless screening systems with ~95% accuracy in detecting impairment, infectious disease, and multiple vital signs.
  • Supported by independent, multicentre clinical validation.
  • Plans to initiate formal medical-device certification processes in multiple jurisdictions, including Southeast Asia.
  • Target applications include enterprise health and safety, hospital triage, and government health programs.
• Consumer Vital Scanning Mobile Application:
  • Planned direct-to-consumer entry leveraging patented imaging technology.
  • Aims to deliver vital sign monitoring via smartphone.
  • Targets the growing digital health and telehealth markets.
• Strategic Rationale & Market Data:
  • Recurring Revenue: SaaS subscriptions, screening-as-a-service, and consumer subscriptions.
  • IP: Proprietary adaptive-simulation engine and patented multispectral imaging algorithms.
  • Market Size: Global AI in healthcare market estimated at $26.6 billion (U.S.) in 2024, projected to reach ~$187.7 billion by 2030 (CAGR ~38.6% from 2025–2030).

Notable Quotes

• "Our validated smarthealth technology provides the data, AI engine and market credibility to scale across enterprise, clinical research and consumer segments," said Dr. Rahul Kushwah, chief operating officer of Predictmedix. "This multivertical approach is designed to diversify revenue and support sustainable long-term growth for our shareholders."